The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis
Official Title: Prospective, Non-randomized, Multicenter Study to Assess the Efficacy and Safety of Oral or Intravenous Paricalcitol Administered Over 6 Months to Patients With Secondary Hyperparathyroidism on Dialysis
Study ID: NCT00537979
Brief Summary: Prospective, non-randomized, multi-center study to assess the efficacy and safety of paricalcitol injection or oral administered over 6 months to patients with secondary hyperparathyroidism on dialysis.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Site Ref # / Investigator 19391, Jojutla Morelos, , Mexico
Site Ref # / Investigator 19389, Mexico City, , Mexico
Site Ref # / Investigator 19390, Mexico City, , Mexico
Site Ref # / Investigator 19393, Mexico City, , Mexico
Site Ref # / Investigator 19395, Mexico City, , Mexico
Site Ref # / Investigator 19392, Mexico D.F., , Mexico
Site Ref # / Investigator 19397, Mexico D.F., , Mexico
Site Ref # / Investigator 19396, Mexico D.F., , Mexico
Site Ref # / Investigator 19394, Mexico D.F., , Mexico
Site Ref # / Investigator 19399, Puebla, , Mexico
Site Ref # / Investigator 19398, Zapopan, , Mexico
Site Ref # / Investigator 19388, Zapopan, , Mexico
Name: Jose-Luis Cañadas, MD
Affiliation: Abbott
Role: STUDY_DIRECTOR